Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons

Molecular Brain Research

Volumn 48, Issue 2, 1997, Pages 333-345

  Laprade, Nathalie ^a   Soghomonian, Jean Jacques ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

aminobutyric acid (GABA); D1 receptor; Dopamine; Glutamate decarboxylase (GAD); Glutamic acid decarboxylase; Hybridization histochemistry, in situ; mRNA; Striato nigral

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; COMPLEMENTARY RNA; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RNA PROBE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE AGONISTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE DECARBOXYLASE; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, COMPLEMENTARY;

ANIMALIA;

EID: 0030880064     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00112-5     Document Type: Article

References (65)

1. 3H]γ-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats. Neurosci. Lett. 121:1992;223-226.
2. Barone P., Tucci I., Parashos S.A., Chase T.N. D-1 dopamine receptor changes after striatal quinolinic acid lesion. Eur. J. Pharmacol. 138:1987;141-145.
3. + and glutamate activates different neurotransmitter release mechanisms in GABAergic neurons: vesicular versus non-vesicular release of GABA. Neuroscience. 54:1993;1019-1034.
4. Bernath S., Zigmond M.J. Dopamine may influence striatal GABA release via three separate mechanisms. Brain Res. 476:1989;373-376.
5. Bernath S., Zigmond M.J. Calcium-independent GABA release from striatal slices: the role of calcium channels. Neuroscience. 36:1990;677-682.
6. Bolam J.P., Powell J.F., Wu J.-Y., Smith A.D. Glutamate decarboxylase-immunoreactive structures in the rat neostriatum: a correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry. J. Comp. Neurol. 237:1985;1-20.
7. E.M. Byrnes, A. Reilly and J.B. Bruno, Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux, Synapse (in press).
8. Caboche J., Vernier P., Rogard M., Julien J.F., Mallet J., Besson M.J. Role of dopaminergic D2 receptors in the regulation of glutamic acid decarboxylase messenger RNA in the striatum of the rat. Eur. J. Neurosci. 4:1992;438-447.
9. Cox K.H., DeLeon D.V., Angerer L.M., Angerer R.C. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymetric RNA probes. Dev. Biol. 101:1984;485-502.
10. 3H]-aminobutyric acid release from cultured mouse cerebral cortex neurons by sulphur-containing excitatory amino acid transmitters candidates: receptor activation mediates two distinct mechanisms of release. J. Neurochem. 57:1991;1388-1397.
11. Engber T.M., Boldry R.C., Kuo S., Chase T.N. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res. 581:1992;261-268.
12. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A.J. Two genes encodes distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
13. Esclapez M.G., Tillakaratne N.J.K., Tobin A.J., Houser C.R. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J. Comp. Neurol. 331:1993;339-362.
14. Esclapez M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A.J. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the two forms. J. Neurosci. 14:1994;1834-1855.
15. Feldblum S., Erlander M.G., Tobin A.J. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34:1993;689-706.
16. Ferré S., O'Connor W.T., Svenningsson P., Björklund L., Lindberg J., Tinner B., Strömberg I., Goldstein M., Ögren S.O., Ungerstedt U., Fredholm B.B., Fuxe K. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopeduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur. J. Neurosci. 8:1996;1545-1553.
17. Floran B., Aceves J., Sierra A., Martinez-Fong D. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett. 116:1990;136-140.
18. Gerfen C.R., Young W.S. Distribution of striato-nigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
19. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striato-nigral and striatopallidal neurons. Science. 250:1990;1429-1432.
20. Gerfen C.R., McGinty J.F., Young W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
21. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15:1992;285-320.
22. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
23. 3H)-γ-aminobutyric acid in the rat neostriatum. II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen Neuroscience. 19:1986;1109-1117.
24. Harrison M.B., Wiley R.G., Wooten G.F. Selective localization of striatal D1 receptors to striato-nigral neurons. Brain Res. 528:1990;317-322.
25. Harrison M.B., Wiley R.G., Wooten G.F. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res. 590:1992;305-310.
26. Hossain M.A., Weiner N. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. J. Pharmacol. Exp. Ther. 275:1995;237-244.
27. Huang K.-X., Walters J.R. Electrophysiological effects of SKF-38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. J. Pharmacol. Exp. Ther. 271:1994;1434-1443.
28. Jiang H.K., McGinty J.F., Hong J.S. Differential modulation of striato-nigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507:1990;57-64.
29. Kaufman D.L., McGinnis J.F., Krieger N.R., Tobin A.J. Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces γ-aminobutyric acid. Science. 232:1986;1138-1140.
30. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions. J. Neurochem. 56:1991;720-723.
31. Kita H., Kitai S.T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 44:1988;346-352.
32. Laprade N., Soghomonian J.-J. Regulation of mRNA levels encoding for two isoforms of glutamate decarboxylase and preproenkephalin in rat striatum by dopaminergic receptors. Mol. Brain Res. 34:1995;65-74.
33. Laprade N., Soghomonian J.-J. Differential regulation of GAD65 and GAD67 in sub-populations of striatal neurons. Soc. Neurosci. Abstr. 21:1995;1428.
34. Laprade N., Soghomonian J.-J. GAD67 and GAD65 mRNA levels are regulated in different striatal neurons following neonatal 6-hydroxydopamine (6-OHDA) lesions and treatment with dopamine receptor agonists. Soc. Neurosci. Abstr. 22:1996;1090.
35. LeMoine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in the rat forebrain. Proc. Natl. Acad. Sci. USA. 87:1990;230-234.
36. LeMoine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1994;418-426.
37. Li S., Sivam S.P., McGinty J.F., Huang Y.S., Hong J.S. Dopaminergic regulation of tachykinin metabolism in the striato-nigral pathway. J. Pharmacol. Exp. Ther. 243:1987;403-408.
38. Li S., Sivam S.P., McGinty J.F., Jiang H.K., Douglass J., Calavetta L., Hong J.S. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmacol. Exp. Ther. 246:1988;403-408.
39. Li S.J., Jiang H.K., Stachowiak M.S., Hudson P.M., Owyang V., Nanry K., Tilson H.A., Hong J.S. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Mol. Brain Res. 8:1990;219-225.
40. Lindefors N., Brené S., Herrera-Marschitz M., Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp. Brain Res. 77:1989;611-620.
41. Martin D.L., Rimwall K. Regulation of γ-aminobutyric acid synthesis in the rat brain. J. Neurochem. 60:1993;395-407.
42. Martin L.P., Waszczak B.L. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striato-nigral terminals via a pertussis toxin-sensitive coupling pathway. J. Neurosci. 14:1994;4494-4506.
43. r 67,000) in the basal ganglia of the rat. J. Comp. Neurol. 318:1992;245-254.
44. Oertel W.H., Mugnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47:1984;233-238.
45. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Orlando, FL, 1986.
46. Pedneault S., Soghomonian J.-J. Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys. Mol. Brain Res. 25:1994;351-354.
47. Penney G.R., Afsharpour S., Kitai S.T. The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience. 17:1986;1011-1045.
48. Pin J.P., Bockaert J. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J. Neurosci. 9:1989;648-656.
49. Qin Z.H., Zhang S.P., Weiss B. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Mol. Brain Res. 21:1994;293-302.
50. Reid M.S., O'Connor W.T., Herrera-Marschitz M., Ungerstedt U. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Brain Res. 519:1990;225-260.
51. Ribak C.E., Vaughn J.E., Roberts E. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunohistochemistry. J. Comp. Neurol. 187:1979;225-228.
52. Segovia J., Tillakaratne N.J.K., Whelan K., Tobin A.J., Gale K. Parallel increase in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway. Brain Res. 529:1990;345-348.
53. Soghomonian J.-J., Chesselet M.-F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse. 11:1992;124-133.
54. Soghomonian J.J., Gonzales C., Chesselet M.-F. Messenger RNAs encoding glutamate decarboxylase are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res. 576:1992;68-79.
55. Soghomonian J.J., Pedneault S., Audet G., Parent A. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated monkeys. J. Neurosci. 14:1994;6256-6265.
56. Solimena M., Aggujaro D., Muntzel C., Dirkx R., Butler M., DeCamilli P., Hayday A. Association of GAD65, but not of GAD67, with the Golgi complex of transfected Chinese hamster ovary cells mediated the N-terminal region. Proc. Natl. Acad. Sci. USA. 90:1993;3073-3077.
57. Trugman J.M., Wooten G.F. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
58. Trugman J.M., James C.L., Wooten G.F. D1/D2 dopamine receptor stimulation by L-dopa. Brain. 114:1991;1429-1440.
59. Vernier V., Julien J.F., Rataboul P., Fourrier O., Fueurstein C., Mallet J. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J. Neurochem. 51:1988;1375-1380.
60. Wang J., Johnson K.M. Regulation of striatal cyclic-3′,5′-adenosine monophosphate accumulation and GABA release by glutamate metabotropic and dopamine D1 receptors. J. Pharm. Exp. Ther. 275:1995;877-884.
61. Weick B.G., Walters J.R. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res. 405:1987;234-246.
62. Weick B.G., Engber T.M., Susel Z., Chase T.N., Walters J.R. Responses of substantia nigra pars reticulata neurons to GABA and SKF-38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration. Brain Res. 523:1990;16-22.
63. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. J. Biol. Chem. 259:1984;380-386.
64. You Z.-B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U., Terenius L. The striato-nigral dynorphin pathway of the rat studied with in vivo microdialysis. II. Effects of dopamine D1 and D2 receptor agonists Neuroscience. 63:1994;427-434.
65. Yung K.K.L., Bolam J.P., Smith A.D., Hersch S.M., Coliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.